ACBD3 and pancreatic adenocarcinoma: As for PAAD, the prognosis was negatively related to ACBD3 expression, including OS [hazard ratio (HR) = 1.63, 95% confidence interval (CI): 1.07–2.46, p = 0.022], DSS (HR = 1.67, 95% CI: 1.05–2.67, p = 0.032), and PFI (HR = 1.32, 95% CI: 0.90–1.94, p = 0.155).